PMID- 15809346 OWN - NLM STAT- MEDLINE DCOM- 20050825 LR - 20211203 IS - 0021-924X (Print) IS - 0021-924X (Linking) VI - 137 IP - 3 DP - 2005 Mar TI - Novel role of the small GTPase Rheb: its implication in endocytic pathway independent of the activation of mammalian target of rapamycin. PG - 423-30 AB - The Ras-homologous GTPase Rheb that is conserved from yeast to human appears to be involved not only in cell growth but also in nutrient uptake. Recent biochemical analysis revealed that tuberous sclerosis complex (TSC), a GTPase-activating protein (GAP), deactivates Rheb and that phosphatidylinositol 3'-kinase (PI3k)-Akt/PKB kinase pathway activates Rheb through inhibition of the GAP-mediated deactivation. Although mammalian target of rapamycin (mTOR) kinase is implicated in the downstream target of Rheb, the direct effector(s) and exact functions of Rheb have not been fully elucidated. Here we identified that Rheb expression in cultured cells induces the formation of large cytoplasmic vacuoles, which are characterized as late endocytic (late endosome- and lysosome-like) components. The vacuole formation required the GTP form of Rheb, but not the activation of the downstream mTOR kinase. These results suggest that Rheb regulates endocytic trafficking pathway independent of the previously identified mTOR pathway. The physiological roles of the two Rheb-dependent signaling pathways are discussed in terms of nutrient uptake and cell growth or cell cycle progression. FAU - Saito, Kota AU - Saito K AD - Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033. FAU - Araki, Yasuhiro AU - Araki Y FAU - Kontani, Kenji AU - Kontani K FAU - Nishina, Hiroshi AU - Nishina H FAU - Katada, Toshiaki AU - Katada T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Biochem JT - Journal of biochemistry JID - 0376600 RN - 0 (Neuropeptides) RN - 0 (Proto-Oncogene Proteins) RN - 0 (RHEB protein, human) RN - 0 (Ras Homolog Enriched in Brain Protein) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (AKT1 protein, human) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.6.5.2 (Monomeric GTP-Binding Proteins) SB - IM MH - Animals MH - Cells, Cultured MH - Cytoplasmic Vesicles/metabolism MH - Dogs MH - Endocytosis/*physiology MH - Endosomes/metabolism MH - Enzyme Activation MH - HeLa Cells MH - Humans MH - Lysosomes/metabolism MH - Monomeric GTP-Binding Proteins/*physiology MH - Neuropeptides/*physiology MH - Phosphatidylinositol 3-Kinases/metabolism MH - Protein Kinases/physiology MH - Protein Serine-Threonine Kinases/metabolism MH - Proto-Oncogene Proteins/metabolism MH - Proto-Oncogene Proteins c-akt MH - Ras Homolog Enriched in Brain Protein MH - Signal Transduction MH - TOR Serine-Threonine Kinases MH - Tissue Distribution MH - Vacuoles/metabolism EDAT- 2005/04/06 09:00 MHDA- 2005/08/27 09:00 CRDT- 2005/04/06 09:00 PHST- 2005/04/06 09:00 [pubmed] PHST- 2005/08/27 09:00 [medline] PHST- 2005/04/06 09:00 [entrez] AID - 137/3/423 [pii] AID - 10.1093/jb/mvi046 [doi] PST - ppublish SO - J Biochem. 2005 Mar;137(3):423-30. doi: 10.1093/jb/mvi046.